Contact

Our portfolio

Skyline Dx

Skyline Dx is a molecular diagnostics company focusing on oncology and infectious diseases. Their platform-agnostic tests range from PCR to Next Generation Sequencing technologies. Skyline Dx partners with discovery and commercial companies to develop and distribute their diagnostic tests. The company is dedicated to advancing precision medicine through innovative molecular diagnostics.

  • Institute: Amsterdam UMC
Industry: Diagnostics, Oncology
  • Founding year: 2013
Visit website

Want to get in contact about Skyline Dx?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

GuanaRep

GuanaRep
Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.
Plantics
Reducing plastic waste and lowering CO2 emissions.

Cellagenics

Cellagenics
Scaling up therapeutic antibody production with STEP® technology.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.

GuanaRep

GuanaRep
Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.
Plantics
Reducing plastic waste and lowering CO2 emissions.

Cellagenics

Cellagenics
Scaling up therapeutic antibody production with STEP® technology.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Explore full AAV portfolio
Contact